Clinical Trial Update: Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing valsartan with amlodipine in postmenopausal women with hypertension has completed and posted results evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• DIOVAN (valsartan)
• NORVASC (amlodipine besylate)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-05-03